These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 11105330)

  • 1. The role of magnesium as antithrombotic therapy.
    Shechter M
    Wien Med Wochenschr; 2000; 150(15-16):343-7. PubMed ID: 11105330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficial antithrombotic effects of the association of pharmacological oral magnesium therapy with aspirin in coronary heart disease patients.
    Shechter M; Merz CN; Paul-Labrador M; Meisel SR; Rude RK; Molloy MD; Dwyer JH; Shah PK; Kaul S
    Magnes Res; 2000 Dec; 13(4):275-84. PubMed ID: 11153897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnesium and myocardial infarction.
    Shechter M; Shechter A
    Clin Calcium; 2005 Nov; 15(11):111-5. PubMed ID: 16272621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low intracellular magnesium levels promote platelet-dependent thrombosis in patients with coronary artery disease.
    Shechter M; Merz CN; Rude RK; Paul Labrador MJ; Meisel SR; Shah PK; Kaul S
    Am Heart J; 2000 Aug; 140(2):212-8. PubMed ID: 10925332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does magnesium have a role in the treatment of patients with coronary artery disease?
    Shechter M
    Am J Cardiovasc Drugs; 2003; 3(4):231-9. PubMed ID: 14728075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Magnesium in coronary artery disease--is there evidence?].
    Kiss K; Stühlinger HG; Glogar HD; Smetana R
    Wien Med Wochenschr; 2000; 150(15-16):325-9. PubMed ID: 11105327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease.
    Shechter M; Merz CN; Paul-Labrador M; Meisel SR; Rude RK; Molloy MD; Dwyer JH; Shah PK; Kaul S
    Am J Cardiol; 1999 Jul; 84(2):152-6. PubMed ID: 10426331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum magnesium in Thai coronary artery disease patients.
    Wannasilp N; Poungvarin N; Pokum S; Leowattana W; Mahanonda N
    J Med Assoc Thai; 2001 Dec; 84 Suppl 3():S645-9. PubMed ID: 12002905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of roxifiban on platelet aggregation and major receptor expression in patients with coronary artery disease for the Roxifiban Oral Compound Kinetics Evaluation Trial-I (ROCKET-I Platelet Substudy).
    Serebruany VL; Malinin AI; O'connor CM; Gurbel PA;
    Am Heart J; 2003 Jul; 146(1):91-8. PubMed ID: 12851613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model.
    Vilahur G; Segalés E; Salas E; Badimon L
    Circulation; 2004 Sep; 110(12):1686-93. PubMed ID: 15381660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term antithrombotic treatment in coronary disease].
    Hodara M; Samama M
    J Mal Vasc; 1983; 8(1):28-32. PubMed ID: 6405004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined antithrombotic therapy for acute coronary syndrome.
    Gawaz M; Müller I; Besta F
    Semin Vasc Med; 2003 May; 3(2):163-76. PubMed ID: 15199479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic therapy for acute myocardial infarction: mechanisms and prevention of deep venous, left ventricular, and coronary artery thromboembolism.
    Chesebro JH; Fuster V
    Circulation; 1986 Nov; 74(5 Pt 2):III1-10. PubMed ID: 3533316
    [No Abstract]   [Full Text] [Related]  

  • 14. Should magnesium therapy be considered for the treatment of coronary heart disease? I. A critical appraisal of current facts and hypotheses.
    Weiss M; Lasserre B
    Magnes Res; 1994 Jun; 7(2):135-44. PubMed ID: 7999528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Secondary prevention after acute myocardial infarction: aspirin, warfarin or both?].
    Reikvam A; Madsen S; Landmark K
    Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1838-40. PubMed ID: 12830258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New strategies in the treatment of acute myocardial infarction].
    Gonzi G; Ardissino D
    Ital Heart J Suppl; 2001 Oct; 2(10):1055-60. PubMed ID: 11723606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Body magnesium--the spark of life].
    Shechter M
    Harefuah; 2011 Jan; 150(1):41-5, 67. PubMed ID: 21449156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Strategies to improve reperfusion with fibrinolytic therapy in ST-T elevation myocardial infarction].
    Jerjes-Sánchez C; Sosa del Angel E; García Sosa A; Reyes Cerezo E; Garza Ruiz A
    Arch Cardiol Mex; 2003; 73(1):46-58. PubMed ID: 12820494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving antithrombotic treatment strategies for acute ST-elevation myocardial infarction.
    Kandzari DE
    Rev Cardiovasc Med; 2006; 7 Suppl 4():S29-37. PubMed ID: 17224888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antithrombotic prophylaxis in patients with ventricular dysfunction: critical review of the literature and new perspectives].
    Scardi S; Mazzone C
    Ital Heart J Suppl; 2003 Mar; 4(3):201-9. PubMed ID: 12784754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.